Royalty Pharma
RPRX
#635
Rank
NZ$69.93 B
Marketcap
NZ$121.02
Share price
0.67%
Change (1 day)
80.46%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: NZ$69.93 Billion

As of November 2026 Royalty Pharma has a market cap of NZ$69.93 Billion. This makes Royalty Pharma the world's 635th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$69.93 B77.08%
2025NZ$39.49 B48.01%
2024NZ$26.68 B0.19%
2023NZ$26.63 B-3%
2022NZ$27.45 B9.57%
2021NZ$25.05 B-6.93%
2020NZ$26.92 B

End of Day market cap according to different sources

On Nov 4th, 2026 the market cap of Royalty Pharma was reported to be:

NZ$68.58 Billion
by Nasdaq info icon info icon
NZ$69.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
NZ$352.76 B 404.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.207 T 3,056.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$2.90 B-95.84%๐Ÿ‡บ๐Ÿ‡ธ USA